503614-91-3 Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 98%
Price | Get Latest Price | |||
Packge | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-12
Product Details
- Product NameEthyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
- CAS No.503614-91-3
- EINECS No.700-890-7
- MFC27H28N4O5
- MW488.54
- AppearanceSolidWhite to Pale Beige
- density 1.34
- Boiling point 758.7±60.0 °C(Predicted)
- storage temp. Sealed in dry,Room Temperature
- Melting point 175 - 180°C
Company Profile Introduction
Cohance Lifesciences (formerly Zandu Chemicals Ltd) are one of the fastest growing Pharmaceutical companies in India that combines the power of Science & Technology together. Established in 1991, we are headquartered in Mumbai and have a state-of- the- art US FDA successfully inspected facility with a capacity of 214 KL along with strong research & development capabilities strategically located in the industrial park of Ankleshwar, Gujarat.
We are a 100% EOU (Export Oriented Unit) engaged in manufacturing and exports of advanced drug intermediates and Active Pharma Ingredients (APIs). We are a specialized Pharma company focusing on the niche therapeutic areas of CNS, ARVs and Controlled substances having tremendous future growth potential. By virtue of this niche focus we have registered an impressive growth over the years.
Our strategy going forward is to further consolidate our pre-eminent position in the high growth therapeutic areas by expanding our capacity for present advanced intermediates and moving up the value chain by expanding capacity for APIs and diversifying product portfolio into the other high growth therapeutic areas.
We are a US FDA, KFDA, WHO-GMP and Japanese MOH accredited company having certifications of ISO 9001, ISO 14001 and OHSAS 18001. We enjoy the CRISIL rating of A(-) and have SAP system in place.
Supplier other products
Recommended supplier
-
VIP1年
- LOBERAN PHARMA
- 503614-91-3 1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester > 99
- Inquiry
- 2024-11-14
-
VIP1年
- Scimplify
- 503614-91-3 99%
- Inquiry
- 2024-10-25
-
VIP1年
- VRUDDISRI PHARMA
- ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1- yl) phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine-3 - carboxylate 503614-91-3 98% to 99%
- Inquiry
- 2024-05-06
-
VIP1年
- ADAARSH PHARMA
- Ethyl 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxopiperidin-1-Yl) Phenyl)-4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine-3-Carboxylate 503614-91-3 99%
- Inquiry
- 2024-05-03
-
VIP1年
- ACTIVZ LIFE SCIENCES (I) PVT LTD
- Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 503614-91-3 98%
- Inquiry
- 2024-03-11
-
VIP1年
- Mekong pharmaceuticals pvt ltd
- Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 503614-91-3 98%
- Inquiry
- 2024-03-02
-
VIP0年
- Glyra Health Care Pvt Ltd
- Ethyl 1-(4-methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 99%
- Inquiry
- 2024-02-21
-
VIP1年
- Cubane Pharmaceuticals LLP
- 503614-91-3 99%
- Inquiry
- 2024-02-08
- Since:2020-01-01
- Address: "215 Atrium, C Wing, 8th Floor, 819-821,_x000D_ Andheri-Kurla Road, Chakala, Andheri (E), Mumbai, M